Clinical Course of SARS-CoV-2 Infection in Adults with ESKD Receiving Outpatient Hemodialysis.

Autor:	Bardossy AC; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Korhonen L; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Schatzman S; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Gable P; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Herzig C; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Brown NE; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Beshearse E; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia., Varela K; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia., Sabour S; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Lyons AK; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Overton R; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Hudson M; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia., Hernandez-Romieu AC; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia., Alvarez J; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Roman K; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Weng M; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia., Soda E; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Patel PR; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Grate C; Fresenius Medical Care, Waltham, Massachusetts., Dalrymple LS; Fresenius Medical Care, Waltham, Massachusetts., Wingard RL; Fresenius Medical Care, Waltham, Massachusetts., Thornburg NJ; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Halpin ASL; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Folster JM; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Tobin-D'Angelo M; Acute Disease Epidemiology Section, Georgia Department of Public Health, Atlanta, Georgia., Lea J; Division of Renal Medicine, Department of Medicine, Emory School of Medicine, Atlanta, Georgia., Apata I; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.; Division of Renal Medicine, Department of Medicine, Emory School of Medicine, Atlanta, Georgia., McDonald LC; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Brown AC; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Kutty PK; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia., Novosad S; COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia.
Jazyk:	angličtina
Zdroj:	Kidney360 [Kidney360] 2021 Sep 22; Vol. 2 (12), pp. 1917-1927. Date of Electronic Publication: 2021 Sep 22 (Print Publication: 2021).
DOI:	10.34067/KID.0004372021
Abstrakt:	Background: Patients with ESKD on maintenance dialysis receive dialysis in common spaces with other patients and have a higher risk of severe SARS-CoV-2 infections. They may have persistently or intermittently positive SARS-CoV-2 RT-PCR tests after infection. We describe the clinical course of SARS-CoV-2 infection and the serologic response in a convenience sample of patients with ESKD to understand the duration of infectivity. Methods: From August to November 2020, we enrolled patients on maintenance dialysis with SARS-CoV-2 infections from outpatient dialysis facilities in Atlanta, Georgia. We followed participants for approximately 42 days. We assessed COVID-19 symptoms and collected specimens. Oropharyngeal (OP), anterior nasal (AN), and saliva (SA) specimens were tested for the presence of SARS-CoV-2 RNA, using RT-PCR, and sent for viral culture. Serology, including neutralizing antibodies, was measured in blood specimens. Results: Fifteen participants, with a median age of 58 (range, 37‒77) years, were enrolled. Median duration of RT-PCR positivity from diagnosis was 18 days (interquartile range [IQR], 8‒24 days). Ten participants had at least one, for a total of 41, positive RT-PCR specimens ≥10 days after symptoms onset. Of these 41 specimens, 21 underwent viral culture; one (5%) was positive 14 days after symptom onset. Thirteen participants developed SARS-CoV-2-specific antibodies, 11 of which included neutralizing antibodies. RT-PCRs remained positive after seroconversion in eight participants and after detection of neutralizing antibodies in four participants; however, all of these samples were culture negative. Conclusions: Patients with ESKD on maintenance dialysis remained persistently and intermittently SARS-CoV-2-RT-PCR positive. However, of the 15 participants, only one had infectious virus, on day 14 after symptom onset. Most participants mounted an antibody response, including neutralizing antibodies. Participants continued having RT-PCR-positive results in the presence of SARS-CoV-2-specific antibodies, but without replication-competent virus detected. Competing Interests: I. Apata reports having consultancy agreements with the CDC. L. S. Dalrymple reports having ownership interest in Fresenius Medical Care (via share options) and owning stock in GE; serving as a member of the Kidney Care Quality Alliance Steering Committee, cochair of the Kidney Health Initiative (KHI) ESRD Global Data Standard Workgroup, and cochair of the National Quality Forum Renal Standing Committee; and serving on the Kidney Medicine editorial board. L. S. Dalrymple also reports her husband owned stock in Bayer, CVS, and GE in the last 36 months, and has shares in The Permanente Medical Group. P. R. Patel reports having other interests in/relationships with American Association of Kidney Patients. R. L. Wingard reports having ownership interest in Fresenius Medical Care North America (via stock options), serving as a member of the KHI Muscle Cramping PRO Project, and serving as a volunteer for Welcome Home of Chattanooga (a nonprofit). All remaining authors have nothing to disclose. (Copyright © 2021 by the American Society of Nephrology.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu